The future of Medicare Part D drug plans - Results from a roundtable discussion

Journal of Managed Care Pharmacy

Volumn 15, Issue 1 SUPPL., 2009, Pages

  Balfour III, Donald C ^a   Evans, Steven ^b   Januska, Jeff ^c   Lee, Helen Y ^d   Lewis, Sonya J ^e   Nolan, Steve R ^f   Noga, Mark ^g   Stemple, Charles ^h   Thapar, Kishan ⁱ  

^a Sharp Rees Stealy Medical Group   (United States)

^b Health Plan of Nevada   (United States)

^c CenCal Health   (United States)

^d Clinical Services   (United States)

^e UNIVERSITY OF COLORADO   (United States)

^f Rocky Mountain Health Plans   (United States)

^g Coventry Health Care ^*  (United States)

^h Humana Healthcare of Ohio   (United States)

ⁱ ProMed HealthCare Administrators   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROTON PUMP INHIBITOR;

ARTICLE; DRUG USE; ELDERLY CARE; FINANCIAL MANAGEMENT; FUNDING; GOVERNMENT REGULATION; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH SERVICE; LAW; MEDICARE; POPULATION GROWTH; PREDICTION; PRESCRIPTION; RISK REDUCTION; SUSTAINABLE DEVELOPMENT; UNITED STATES;

AGED; CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); DRUG PRESCRIPTIONS; GOVERNMENT REGULATION; HUMANS; INSURANCE BENEFITS; MEDICARE PART D; NEGOTIATING; UNITED STATES;

EID: 59149093314     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Henrv J. Kaiser Family Foundation. Medicare: a primer March 2007. Available at: www.kff.org/medicare/upload/7615.pdf. Accessed December 18, 2008.
2. He W, Sengupta M. Velkoff V, DeBarros K U.S. Census Bureau, Current population reports, P23-209, 65+ in the United States: 2005. Washington, DC: U.S. Government Printing Office: 2003.
3. Social Security Administration. A Summary of the 2008 Annual Reports: Social Security and Medicare Board of Trustees. Available at: www.ssa.gov/OACT/TRSUM/trsummary.html. Accessed September 22, 2008.
4. National Coalition on Health Care Facts on Health Care Costs. www.nchc.org/documents/cost_fact_sheet_2008.pdf Accessed December 18. 2008.
5. Hoadley J, Hargrave E. Merrell K, Cubanski J. Neuman T. Medicare Part D 2008 data spotlight: benefit design Henry J. Kaiser Family Foundation. Available at: www.kff.org/medicare/upload/7713pdf. Accessed September 22, 2008.
6. Hoadley J, Hargrave E. Cubanskij. Neuman T. Medicare prescription drug plans in 2008 and key changes since 2000: summary, of findings. Henry J, Kaiser Family Foundation. Available at: www.kff.org/medicare/upload/ 7762.pdf. Accessed September 22. 2008
7. Carroll J. Managed Medicare revitalized: feel-good plan of the decade. Manag Care. 2006:15(9):22-24, 26-28.33. Available at: www.managedcaremag.com/archives/0609/0609.medicare.html. Accessed December 18, 2008.
8. Centers for Medicare & Medicaid Services. Press Releases. Lower Medicare Part D costs than expected in 2009. Available at: www.cms.hhs.gov/apps/media/press/release.asp?Counter= 3240&intNumPerPage=10&checkDate=&checkKey=&srchType= 1&numDays=3500&srchOPt=0&srchData=&keywordTypc= All&chkNewsType=1%2C+2%2C+3%2C+4%2C+5&intPage=&showAll= &Year=&year=&desc=&cboOrdgr=date. Accessed September 22, 2008
9. Hoadley J. Hargrave E, Cubanski J. Neuman T. The Medicare Part D coverage gap: Costs and consequences in 2007. Henry J. Kaiser Family Foundation Available at: www.kff.org/medicare/upload/7811.pdf. Accessed September 22. 2008.
10. Frank R, Newhouse J. Should drug prices be negotiated under Part D of Medicare? And if so, how? [i Health Aff (Millwood) i]. 2008;27(1):33-43.
11. United States House of Representatives. Committee on Oversight and Government Reform Majority Staff. Medicare Part D: pricing and manufacturer windfalls. Available at: www.oversight.house.gov/documents/ 20080724101850.pdf. Accessed September 23. 2008.
12. Hahn J. CRS Report for Congress. Federal drug price negotiation: implications for Medicare Part D. Available at: www.policyarchive.org/ bitstream/handle/10207/3053/RL33782_20070105.pdf?sequence=1. Accessed October 9. 2008
13. Academy of Managed Care Pharmacy. Future of Medicare Part D: Competitive Model. http://69.0.204.76/amcp.ark?p=AA5B4A21. Accessed September 23, 2008.
14. Academy of Managed Care Pharmacy. Future of Medicare Part D: Reliance on Medicare Part D plan sponsors to negotiate prices with pharmaceutical manufacturers. Available at: http://69.0.20476/amcp. ark?p=AA5B4A21. Accessed September 23, 2008.
15. Academy of Managed Care Pharmacy. Future of Medicare Part D: Formularies offered by Part D insurance plans provide patients with access to effective, safe, and affordable medications. Available at: http://69.0.204.76/amcp.ark?p=AA5B4A21. Accessed September 23, 2008.